马吉催化剂通过调节Th1/Th2/Treg/Th17平衡来缓解喘
Yuanjun Liu1, Haixia Liu2, Qi Shao1
1Beijing Key Laboratory, Traditional Chinese Medicine School, Beijing University of Chinese Medicine, Beijing, China.
International archives of allergy and immunology
|May 15, 2024
概括
在喘模型中,MJC有效降低了呼吸道炎症和高反应性. 这种传统药物平衡T辅助细胞子集,表明它有可能成为一种新的抗喘疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 在喘等炎症性疾病中,T细胞至关重要.
- 研究喘治疗的传统疗法至关重要.
研究的目的:
- 为了评估马吉催化剂 (MJC) 对喘的影响.
- 阐明喘中MJC的潜在机制.
主要方法:
- 评估了呼吸道炎症,炎症细胞透和细胞因子水平 (IL-4,IL-10,IL-17,IFN-γ).
- 量化了T辅助细胞种群 (Th2,Treg,Th17,Th1) 和关键转录因子 (GATA-3,Foxp3,RORγt,T-bet).
主要成果:
- MJC降低了呼吸道阻力,炎症细胞透,以及IL-4和IL-17的水平.
- MJC增加了IFN-γ和IL-10水平,将T细胞平衡转向Th1和Treg表型.
- MJC降低了Th2和Th17细胞的调节,同时提高了Th1和Treg细胞的调节,影响了关键的转录因子.
结论:
- 通过调节Th1/Th2/Treg/Th17平衡,MJC可以改善气道过敏反应和炎症.
- MJC显示出作为一种用于喘治疗的新型治疗剂的前景.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
277
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
277
Asthma: Pathogenesis and Management
389
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
389
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Muscarinic Receptor Antagonists
288
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
288


